THANK YOU FOR SUBSCRIBING
Fourier Intelligence raises Series B+ funding following Series B round, powered by Qianhai FOF equity
Fremont, CA: A Shanghai-based robotics startup, Fourier Intelligence, completed Series B+ funding round raising more than tens of thousands of yuan.
Fourier Intelligence is a technology-based company that infuses creativity into the foundational development of exoskeleton and rehabilitation robotics since the year 2015. Along with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation solutions with interconnectable intelligent robotics by elevating the user experience with an easy-to-use intuitive system to enhance the quality of lives among both patients and therapists.
Qianhai FOF, an equity firm from Shenzhen-based, contributed as the sole investor in the funding round. In addition to the investment in Series B round of financing, Shenzhen Guozhong Capital Management Co., Ltd., IDG Capital, and Volcanics Venture, and many other players have planned to share the proceeds.
The proceeds collected from the Series B and Series B+ rounds is estimated to be RMB 100 million (US$14.11m), and it will mainly be utilized to spur R&D, facilitate marketing efforts, and formulate an intelligent rehabilitation ecosystem.
The intuitive and easy user interface of the robotic device is specifically designed for those patients who are discharged from the hospital or clinical setting to carry on with rehabilitation training at home at any time.
The rehabilitation device designs allow home users to integrate with the Fourier Infinity Net System (FINS). The data, after it is collected, enables synchronized and shared among hospitals, communities, and homes. Fourier Intelligence gave therapists, evacuate access data, and evaluate patients' home rehabilitation training programs efficiently.
Founded in 2015 by Alex Gu, founder, and chief executive, Fourier Intelligence is a designer and developer of mass-market rehabilitation robotics. Over the last few years, the company has to sign a Memorandums of Understanding (MoUs) with top players in the global rehabilitation scene, including but not restricted to Shirley Ryan AbilityLab, the University of Melbourne, ETH Zurich, to establish joint labs.